- • Up to 20% off your first purchase
- • Bulk quantities available
- • Citation Reward application
Sample Application
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Protocol Library
 |
 |
Myeloperoxidase (MPO) antibody and antigen (Recombinant protein)
Diagnostic Myeloperoxidase (MPO) antibodies (anti-Myeloperoxidase, anti-MPO) and antigens (recombinant Myeloperoxidase (MPO) protein) for Cardiovascular disease MPO detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to
Neurodegenerative diseases diagnostics
products collection
>>
Product information
| Catalog No. | Description | US $ Price (per mg) |
|---|---|---|
| GMP-h-MPO-Ag01 | Recombinant human MPO Protein | 3090 |
| GMP-h-MPO-Ab01 | Anti-human MPO mouse monoclonal antibody (mAb) | 1953 |
| GMP-h-MPO-Ab02 | Anti-human MPO mouse monoclonal antibody (mAb) | 1953 |
| GMP-h-MPO-Ab03 | Anti-human MPO human monoclonal antibody (mAb) | 1953 |
| GMP-h-MPO-Ab04 | Anti-human MPO human monoclonal antibody (mAb) | 1953 |
Size： 1mg | 10mg | 100mg
Product Description
| Cat No. of Products | GMP-h-MPO-Ag01 |
| Product Name | Recombinant human MPO Protein |
| Target/Biomarker | Myeloperoxidase(MPO) |
| Expression platform | mammalian |
| Isotypes | Recombinant Antigen |
| Bioactivity validation | Myeloperoxidase (MPO) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in MPO level test of Cardiovascular disease (vascular inflammation) and related syndrome evaluation. |
| Products description | Recombinant human MPO Protein was expressed in mammalian expression system and is expressed with 6 HIS tag at the C-terminus. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT. |
| Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. of Products | GMP-h-MPO-Ab01, GMP-h-MPO-Ab02 |
| Product Name | Anti-human MPO mouse monoclonal antibody (mAb) |
| Target/Biomarker | Myeloperoxidase(MPO) |
| Expression platform | CHO |
| Isotypes | Mouse IgG |
| Bioactivity validation | Human Myeloperoxidase (MPO) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Myeloperoxidase (MPO) antibodies in MPO level test of Cardiovascular disease (vascular inflammation) and related syndrome evaluation. |
| Tag | mFc |
| Products description | Anti-human MPO mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. |
| Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. of Products | GMP-h-MPO-Ab03, GMP-h-MPO-Ab04 |
| Product Name | Anti-human MPO human monoclonal antibody (mAb) |
| Target/Biomarker | Myeloperoxidase(MPO) |
| Expression platform | CHO |
| Isotypes | Human lgG1 |
| Bioactivity validation | Human Myeloperoxidase (MPO) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Myeloperoxidase (MPO) antibodies in MPO level test of Cardiovascular disease (vascular inflammation) and related syndrome evaluation. |
| Tag | hFc |
| Products description | Anti-human MPO human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. |
| Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Autoantibodies to MPO (MPO antineutrophil cytoplasmic antibodies: ANCA) occur in several diseases and may be involved in the pathogenesis of vascular inflammation in patients with microscopic polyangiitis (MPA).(1,2) Patients with MPA often develop MPO ANCA and may present with azotemia secondary to glomerulonephritis (pauci-immune necrotizing glomerulonephritis). MPO ANCA are not specific for MPA, and also may be detected in patients with systemic lupus erythematosus with or without lupus nephritis, Goodpasture syndrome and Churg-Strauss syndrome. Lupus nephritis and Goodpasture syndrome, as well as Wegener granulomatosis may present with azotemia and progressive renal failure. It is not possible to distinguish among these diseases on the basis of clinical signs and symptoms; autoantibody testing may be helpful.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Facebook
LinkedIn
Twitter
Comments